BIONPHARMA INC FDA Approval NDA 022152

NDA 022152

BIONPHARMA INC

FDA Drug Application

Application #022152

Documents

Letter2008-07-31
Letter2013-02-28
Letter2013-06-18
Letter2014-03-10
Letter2014-09-03
Label2013-03-01
Label2013-03-01
Label2013-06-18
Label2014-09-03
Review2009-08-25
Letter2009-02-06
Letter2009-05-04
Letter2013-02-28
Label2008-08-07
Label2009-05-12
Label2014-03-10
Summary Review2009-08-25
Letter2019-12-30
Label2020-01-02
Label2021-12-01
Medication Guide2021-12-01
Letter2021-12-01

Application Sponsors

NDA 022152BIONPHARMA INC

Marketing Status

Discontinued001
Discontinued002
Discontinued003

Application Products

001CAPSULE, DELAYED RELEASE;ORAL125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1STAVZORVALPROIC ACID
002CAPSULE, DELAYED RELEASE;ORAL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1STAVZORVALPROIC ACID
003CAPSULE, DELAYED RELEASE;ORAL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1STAVZORVALPROIC ACID

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2008-07-29STANDARD
LABELING; LabelingSUPPL2AP2009-04-23901 REQUIRED
LABELING; LabelingSUPPL3AP2013-02-26STANDARD
LABELING; LabelingSUPPL4AP2013-02-26STANDARD
LABELING; LabelingSUPPL5AP2013-06-14STANDARD
LABELING; LabelingSUPPL6AP2014-03-07STANDARD
LABELING; LabelingSUPPL7AP2014-08-28STANDARD
LABELING; LabelingSUPPL8AP2019-12-26STANDARD
LABELING; LabelingSUPPL9AP2021-11-30STANDARD

Submissions Property Types

ORIG1Null31
SUPPL3Null15
SUPPL4Null6
SUPPL5Null6
SUPPL6Null6
SUPPL7Null7
SUPPL8Null33
SUPPL9Null6

CDER Filings

BIONPHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 22152
            [companyName] => BIONPHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"STAVZOR","activeIngredients":"VALPROIC ACID","strength":"125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE, DELAYED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"STAVZOR","activeIngredients":"VALPROIC ACID","strength":"250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE, DELAYED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"STAVZOR","activeIngredients":"VALPROIC ACID","strength":"500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE, DELAYED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"12\/26\/2019","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/022152s008lbl.pdf\"}]","notes":""},{"actionDate":"08\/28\/2014","submission":"SUPPL-7","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/022152s007lbl.pdf\"}]","notes":""},{"actionDate":"03\/07\/2014","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/022152s006lbl.pdf\"}]","notes":""},{"actionDate":"06\/14\/2013","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022152s005lbl.pdf\"}]","notes":""},{"actionDate":"02\/26\/2013","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022152s003s004lbl.pdf\"}]","notes":""},{"actionDate":"02\/26\/2013","submission":"SUPPL-4","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022152s003s004lbl.pdf\"}]","notes":""},{"actionDate":"02\/26\/2013","submission":"SUPPL-3","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022152s003s004lbl.pdf\"}]","notes":""},{"actionDate":"02\/26\/2013","submission":"SUPPL-3","supplementCategories":"REMS-Proposal","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/022152s003s004lbl.pdf\"}]","notes":""},{"actionDate":"04\/23\/2009","submission":"SUPPL-2","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022152s002lbl.pdf\"}]","notes":""},{"actionDate":"07\/29\/2008","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/022152lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"STAVZOR","submission":"VALPROIC ACID","actionType":"125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE, DELAYED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"STAVZOR","submission":"VALPROIC ACID","actionType":"250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE, DELAYED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"STAVZOR","submission":"VALPROIC ACID","actionType":"500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE, DELAYED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-12-26
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.